Open access
1,264
Views
34
CrossRef citations to date
0
Altmetric
Reviews
‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
Ying Zhang1 Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA;2 Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, ChinaCorrespondence[email protected]
, Kwok Chiu Chang3 Tuberculosis and Chest Service, Department of Health, Hong Kong, China
, Chi-Chiu Leung3 Tuberculosis and Chest Service, Department of Health, Hong Kong, China
, Wing Wai Yew4 Department of Microbiology, Chinese University of Hong Kong, Hong Kong, China
, Brigitte Gicquel5 Unite de Génétique Mycobactérienne, Institut Pasteur, 28 rue du Dr. Roux 75015 Paris, France
, Dorothy Fallows6 Laboratory of Mycobacterial Immunity and Pathogenesis, Public Health Research Institute at University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
, Gilla Kaplan6 Laboratory of Mycobacterial Immunity and Pathogenesis, Public Health Research Institute at University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA
, Richard E Chaisson7 Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
& Wenhong Zhang2 Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
show all
Pages 1-4
|
Received 13 Apr 2012, Accepted 12 Jun 2012, Published online: 25 Jan 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.